Figure 2
Kaplan–Meier survival curves of overall survival (OS) in the CEBPAsingle−mut patients with and without concurrent FLT3/ITD, FLT3/TKD, MLL/PTD or AML1/RUNX1 mutation.
Figure 2 | British Journal of Cancer
Kaplan–Meier survival curves of overall survival (OS) in the CEBPAsingle−mut patients with and without concurrent FLT3/ITD, FLT3/TKD, MLL/PTD or AML1/RUNX1 mutation.
